{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:04:12Z","timestamp":1791205452857,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:00:00Z","timestamp":1379980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:00:00Z","timestamp":1379980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1038\/mp.2013.115","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T07:59:36Z","timestamp":1380009576000},"page":"986-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Antidepressant-like and anxiolytic-like effects following activation of the \u03bc-\u03b4 opioid receptor heteromer in the nucleus accumbens"],"prefix":"10.1038","volume":"19","author":[{"given":"N","family":"Kabli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Balboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B F","family":"O'Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,24]]},"reference":[{"key":"BFmp2013115_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28\u201340.","journal-title":"Am J Psychiatry"},{"key":"BFmp2013115_CR2","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1176\/ajp.149.9.1162","volume":"149","author":"DF Darko","year":"1992","unstructured":"Darko DF, Risch SC, Gillin JC, Golshan S . Association of beta-endorphin with specific clinical symptoms of depression. Am J Psychiatry 1992; 149: 1162\u20131167.","journal-title":"Am J Psychiatry"},{"key":"BFmp2013115_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1001\/archpsyc.63.11.1199","volume":"63","author":"SE Kennedy","year":"2006","unstructured":"Kennedy SE, Koeppe RA, Young EA, Zubieta JK . Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 2006; 63: 1199\u20131208.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2013115_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/archpsyc.60.11.1145","volume":"60","author":"JK Zubieta","year":"2003","unstructured":"Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry 2003; 60: 1145\u20131153.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2013115_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/JCP.0b013e31818638a4","volume":"28","author":"PW Nyhuis","year":"2008","unstructured":"Nyhuis PW, Gastpar M, Scherbaum N . Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy. J Clin Psychopharmacol 2008; 28: 593\u2013595.","journal-title":"J Clin Psychopharmacol"},{"key":"BFmp2013115_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00004714-199502000-00008","volume":"15","author":"JA Bodkin","year":"1995","unstructured":"Bodkin JA, Zornberg GL, Lukas SE, Cole JO . Buprenorphine treatment of refractory depression. J Clin Psychopharmacol 1995; 15: 49\u201357.","journal-title":"J Clin Psychopharmacol"},{"key":"BFmp2013115_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(82)90727-9","volume":"2","author":"HM Emrich","year":"1982","unstructured":"Emrich HM, Vogt P, Herz A, Kissling W . Antidepressant effects of buprenorphine. Lancet 1982; 2: 709.","journal-title":"Lancet"},{"key":"BFmp2013115_CR8","first-page":"77","volume":"32","author":"HM Emrich","year":"1982","unstructured":"Emrich HM . A possible role of opioid substances in depression. Adv Biochem Psychopharmacol 1982; 32: 77\u201384.","journal-title":"Adv Biochem Psychopharmacol"},{"key":"BFmp2013115_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1749-6632.1982.tb39483.x","volume":"398","author":"HM Emrich","year":"1982","unstructured":"Emrich HM, Vogt P, Herz A . Possible antidepressive effects of opioids: action of buprenorphine. Ann N Y Acad Sci 1982; 398: 108\u2013112.","journal-title":"Ann N Y Acad Sci"},{"key":"BFmp2013115_CR10","first-page":"29","volume":"17","author":"I Extein","year":"1981","unstructured":"Extein I, Pickar D, Gold MS, Gold PW, Pottash AL, Sweeney DR et al. Methadone and morphine in depression [proceedings]. Psychopharmacol Bull 1981; 17: 29\u201333.","journal-title":"Psychopharmacol Bull"},{"key":"BFmp2013115_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.npep.2009.06.004","volume":"43","author":"KM Hegadoren","year":"2009","unstructured":"Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N . The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides 2009; 43: 341\u2013353.","journal-title":"Neuropeptides"},{"key":"BFmp2013115_CR12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1476-5381.2010.00944.x","volume":"161","author":"N Kabli","year":"2010","unstructured":"Kabli N, Martin N, Fan T, Nguyen T, Hasbi A, Balboni G et al. Agonists at the delta-opioid receptor modify the binding of micro-receptor agonists to the micro-delta receptor hetero-oligomer. Br J Pharmacol 2010; 161: 1122\u20131136.","journal-title":"Br J Pharmacol"},{"key":"BFmp2013115_CR13","doi-asserted-by":"publisher","first-page":"26128","DOI":"10.1074\/jbc.M000345200","volume":"275","author":"SR George","year":"2000","unstructured":"George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 2000; 275: 26128\u201326135.","journal-title":"J Biol Chem"},{"key":"BFmp2013115_CR14","doi-asserted-by":"publisher","first-page":"38478","DOI":"10.1074\/jbc.M505644200","volume":"280","author":"T Fan","year":"2005","unstructured":"Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, George SR . A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem 2005; 280: 38478\u201338488.","journal-title":"J Biol Chem"},{"key":"BFmp2013115_CR15","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1073\/pnas.0307601101","volume":"101","author":"I Gomes","year":"2004","unstructured":"Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA . A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA 2004; 101: 5135\u20135139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013115_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1124\/jpet.111.179093","volume":"337","author":"L Milan-Lobo","year":"2011","unstructured":"Milan-Lobo L, Whistler JL . Heteromerization of the mu- and delta-opioid receptors produces ligand-biased antagonism and alters mu-receptor trafficking. J Pharmacol Exp Ther 2011; 337: 868\u2013875.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2013115_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainres.2005.11.005","volume":"1069","author":"MM Torregrossa","year":"2006","unstructured":"Torregrossa MM, Jutkiewicz EM, Mosberg HI, Balboni G, Watson SJ, Woods JH . Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Res 2006; 1069: 172\u2013181.","journal-title":"Brain Res"},{"key":"BFmp2013115_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0893-133X(01)00413-4","volume":"26","author":"DC Broom","year":"2002","unstructured":"Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH . Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 2002; 26: 744\u2013755.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2013115_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/sj.bjp.0706686","volume":"147","author":"SA Perrine","year":"2006","unstructured":"Perrine SA, Hoshaw BA, Unterwald EM . Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol 2006; 147: 864\u2013872.","journal-title":"Br J Pharmacol"},{"key":"BFmp2013115_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1124\/mi.6.3.7","volume":"6","author":"EM Jutkiewicz","year":"2006","unstructured":"Jutkiewicz EM . The antidepressant -like effects of delta-opioid receptor agonists. Mol Interv 2006; 6: 162\u2013169.","journal-title":"Mol Interv"},{"key":"BFmp2013115_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1254\/jjp.90.1","volume":"90","author":"DC Broom","year":"2002","unstructured":"Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH . Behavioral effects of delta-opioid receptor agonists: potential antidepressants? Jpn J Pharmacol 2002; 90: 1\u20136.","journal-title":"Jpn J Pharmacol"},{"key":"BFmp2013115_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0091-3057(78)90051-5","volume":"9","author":"AJ Kastin","year":"1978","unstructured":"Kastin AJ, Scollan EL, Ehrensing RH, Schally AV, Coy DH . Enkephalin and other peptides reduce passiveness. Pharmacol Biochem Behav 1978; 9: 515\u2013519.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFmp2013115_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.peptides.2007.10.012","volume":"29","author":"R Vergura","year":"2008","unstructured":"Vergura R, Balboni G, Spagnolo B, Gavioli E, Lambert DG, McDonald J et al. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 2008; 29: 93\u2013103.","journal-title":"Peptides"},{"key":"BFmp2013115_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0014-2999(92)90356-9","volume":"216","author":"A Baamonde","year":"1992","unstructured":"Baamonde A, Dauge V, Ruiz-Gayo M, Fulga IG, Turcaud S, Fournie-Zaluski MC et al. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. Eur J Pharmacol 1992; 216: 157\u2013166.","journal-title":"Eur J Pharmacol"},{"key":"BFmp2013115_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2011.06.008","volume":"32","author":"AA Pradhan","year":"2011","unstructured":"Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL . The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 2011; 32: 581\u2013590.","journal-title":"Trends Pharmacol Sci"},{"key":"BFmp2013115_CR26","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1111\/j.0953-816X.2004.03339.x","volume":"19","author":"G Scherrer","year":"2004","unstructured":"Scherrer G, Befort K, Contet C, Becker J, Matifas A, Kieffer BL . The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur J Neurosci 2004; 19: 2239\u20132248.","journal-title":"Eur J Neurosci"},{"key":"BFmp2013115_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1054\/npep.2002.0900","volume":"36","author":"C Gaveriaux-Ruff","year":"2002","unstructured":"Gaveriaux-Ruff C, Kieffer BL . Opioid receptor genes inactivated in mice: the highlights. Neuropeptides 2002; 36: 62\u201371.","journal-title":"Neuropeptides"},{"key":"BFmp2013115_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/00001756-200506210-00009","volume":"16","author":"S Oleskevich","year":"2005","unstructured":"Oleskevich S, Leck KJ, Matthaei K, Hendry IA . Enhanced serotonin response in the hippocampus of Galphaz protein knock-out mice. Neuroreport 2005; 16: 921\u2013925.","journal-title":"Neuroreport"},{"key":"BFmp2013115_CR29","doi-asserted-by":"crossref","unstructured":"Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E et al. Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 2010; 3, ra54.","DOI":"10.1126\/scisignal.2000807"},{"key":"BFmp2013115_CR30","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1176\/ajp.2006.163.10.1784","volume":"163","author":"J Epstein","year":"2006","unstructured":"Epstein J, Pan H, Kocsis JH, Yang Y, Butler T, Chusid J et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 2006; 163: 1784\u20131790.","journal-title":"Am J Psychiatry"},{"key":"BFmp2013115_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1176\/appi.ajp.2008.07081336","volume":"166","author":"EE Forbes","year":"2009","unstructured":"Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 2009; 166: 64\u201373.","journal-title":"Am J Psychiatry"},{"key":"BFmp2013115_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biopsych.2009.09.013","volume":"67","author":"BH Bewernick","year":"2011","unstructured":"Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2011; 67: 110\u2013116.","journal-title":"Biol Psychiatry"},{"key":"BFmp2013115_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3109\/15622975.2011.583940","volume":"12","author":"C Grubert","year":"2011","unstructured":"Grubert C, Hurlemann R, Bewernick BH, Kayser S, Hadrysiewicz B, Axmacher N et al. Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry 2011; 12: 516\u2013527.","journal-title":"World J Biol Psychiatry"},{"key":"BFmp2013115_CR34","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1021\/jm020336e","volume":"45","author":"G Balboni","year":"2002","unstructured":"Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Jinsmaa Y et al. Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem 2002; 45: 5556\u20135563.","journal-title":"J Med Chem"},{"key":"BFmp2013115_CR35","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson CR . The Rat Brain in Stereotaxic Coordinates Fourth ed. Academic Press: New York, NY, USA, 1998."},{"key":"BFmp2013115_CR36","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","volume":"285","author":"SR Schwarze","year":"1999","unstructured":"Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF . In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999; 285: 1569\u20131572.","journal-title":"Science"},{"key":"BFmp2013115_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1124\/mol.108.053728","volume":"76","author":"SC Mao","year":"2009","unstructured":"Mao SC, Lin HC, Gean PW . Augmentation of fear extinction by infusion of glycine transporter blockers into the amygdala. Mol Pharmacol 2009; 76: 369\u2013378.","journal-title":"Mol Pharmacol"},{"key":"BFmp2013115_CR38","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1126\/science.1116894","volume":"310","author":"K Brebner","year":"2005","unstructured":"Brebner K, Wong TP, Liu L, Liu Y, Campsall P, Gray S et al. Nucleus accumbens long-term depression and the expression of behavioral sensitization. Science 2005; 310: 1340\u20131343.","journal-title":"Science"},{"key":"BFmp2013115_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbrc.2007.01.125","volume":"355","author":"J Kim","year":"2007","unstructured":"Kim J, Lee S, Park H, Song B, Hong I, Geum D et al. Blockade of amygdala metabotropic glutamate receptor subtype 1 impairs fear extinction. Biochem Biophys Res Commun 2007; 355: 188\u2013193.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFmp2013115_CR40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M . Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47: 379\u2013391.","journal-title":"Eur J Pharmacol"},{"key":"BFmp2013115_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0149-7634(94)90039-6","volume":"18","author":"I Lucki","year":"1994","unstructured":"Lucki I, Singh A, Kreiss DS . Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 1994; 18: 85\u201395.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFmp2013115_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00213-010-1980-y","volume":"212","author":"JF Randall-Thompson","year":"2010","unstructured":"Randall-Thompson JF, Pescatore KA, Unterwald EM . A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors. Psychopharmacology (Berl) 2010; 212: 585\u2013595.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2013115_CR43","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.neuropharm.2004.02.003","volume":"46","author":"S Matsuzaki","year":"2004","unstructured":"Matsuzaki S, Ikeda H, Akiyama G, Sato M, Moribe S, Suzuki T et al. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats. Neuropharmacology 2004; 46: 1089\u20131096.","journal-title":"Neuropharmacology"},{"key":"BFmp2013115_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0006-8993(92)90904-N","volume":"584","author":"MF Hawkins","year":"1992","unstructured":"Hawkins MF, Cubic B, Baumeister AA, Barton C . Microinjection of opioid antagonists into the substantia nigra reduces stress-induced eating in rats. Brain Res 1992; 584: 261\u2013265.","journal-title":"Brain Res"},{"key":"BFmp2013115_CR45","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0196-9781(97)00182-4","volume":"18","author":"D Braida","year":"1997","unstructured":"Braida D, Paladini E, Gori E, Sala M . Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death. Peptides 1997; 18: 1189\u20131195.","journal-title":"Peptides"},{"key":"BFmp2013115_CR46","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1046\/j.1460-9568.2002.01915.x","volume":"15","author":"BL Schmidt","year":"2002","unstructured":"Schmidt BL, Tambeli CH, Levine JD, Gear RW . mu\/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur J Neurosci 2002; 15: 861\u2013868.","journal-title":"Eur J Neurosci"},{"key":"BFmp2013115_CR47","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.expneurol.2011.03.021","volume":"229","author":"RW Gear","year":"2011","unstructured":"Gear RW, Levine JD . Nucleus accumbens facilitates nociception. Exp Neurol 2011; 229: 502\u2013506.","journal-title":"Exp Neurol"},{"key":"BFmp2013115_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neulet.2006.01.052","volume":"399","author":"W Xiong","year":"2006","unstructured":"Xiong W, Yu LC . Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats. Neurosci Lett 2006; 399: 167\u2013170.","journal-title":"Neurosci Lett"},{"key":"BFmp2013115_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0006-8993(02)02594-5","volume":"940","author":"Y Li","year":"2002","unstructured":"Li Y, Li JJ, Yu LC . Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect. Brain Res 2002; 940: 69\u201378.","journal-title":"Brain Res"},{"key":"BFmp2013115_CR50","first-page":"880","volume":"60","author":"Z Rogoz","year":"2008","unstructured":"Rogoz Z, Skuza G, Leskiewicz M, Budziszewska B . Effects of co-administration of fluoxetine or tianeptine with metyrapone on immobility time and plasma corticosterone concentration in rats subjected to the forced swim test. Pharmacol Rep 2008; 60: 880\u2013888.","journal-title":"Pharmacol Rep"},{"key":"BFmp2013115_CR51","first-page":"615","volume":"54","author":"E Tatarczynska","year":"2002","unstructured":"Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E . Effects of combined administration of 5-HT1A and\/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. Pol J Pharmacol 2002; 54: 615\u2013623.","journal-title":"Pol J Pharmacol"},{"key":"BFmp2013115_CR52","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1017\/S1461145709000236","volume":"12","author":"E Berrocoso","year":"2009","unstructured":"Berrocoso E, Mico JA . Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. Int J Neuropsychopharmacol 2009; 12: 1033\u20131044.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp2013115_CR53","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","volume":"29","author":"SC Dulawa","year":"2005","unstructured":"Dulawa SC, Hen R . Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 2005; 29: 771\u2013783.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFmp2013115_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M . Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149\u2013167.","journal-title":"J Neurosci Methods"},{"key":"BFmp2013115_CR55","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1523\/JNEUROSCI.21-09-03242.2001","volume":"21","author":"H Wang","year":"2001","unstructured":"Wang H, Pickel VM . Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors. J Neurosci 2001; 21: 3242\u20133250.","journal-title":"J Neurosci"},{"key":"BFmp2013115_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.902720102","volume":"272","author":"VM Pickel","year":"1988","unstructured":"Pickel VM, Towle AC, Joh TH, Chan J . Gamma-aminobutyric acid in the medial rat nucleus accumbens: ultrastructural localization in neurons receiving monosynaptic input from catecholaminergic afferents. J Comp Neurol 1988; 272: 1\u201314.","journal-title":"J Comp Neurol"},{"key":"BFmp2013115_CR57","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1523\/JNEUROSCI.16-13-04162.1996","volume":"16","author":"AL Svingos","year":"1996","unstructured":"Svingos AL, Moriwaki A, Wang JB, Uhl GR, Pickel VM . Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin. J Neurosci 1996; 16: 4162\u20134173.","journal-title":"J Neurosci"},{"key":"BFmp2013115_CR58","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1523\/JNEUROSCI.18-05-01923.1998","volume":"18","author":"AL Svingos","year":"1998","unstructured":"Svingos AL, Clarke CL, Pickel VM . Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin. J Neurosci 1998; 18: 1923\u20131933.","journal-title":"J Neurosci"},{"key":"BFmp2013115_CR59","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1523\/JNEUROSCI.17-07-02585.1997","volume":"17","author":"AL Svingos","year":"1997","unstructured":"Svingos AL, Moriwaki A, Wang JB, Uhl GR, Pickel VM . mu-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J Neurosci 1997; 17: 2585\u20132594.","journal-title":"J Neurosci"},{"key":"BFmp2013115_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuropharm.2008.05.012","volume":"55","author":"L Hipolito","year":"2008","unstructured":"Hipolito L, Sanchez-Catalan MJ, Zanolini I, Polache A, Granero L . Shell\/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens. Neuropharmacology 2008; 55: 183\u2013189.","journal-title":"Neuropharmacology"},{"key":"BFmp2013115_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuroscience.2005.03.065","volume":"135","author":"N Hirose","year":"2005","unstructured":"Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H et al. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 2005; 135: 213\u2013225.","journal-title":"Neuroscience"},{"issue":"Suppl 3","key":"BFmp2013115_CR62","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/00004850-199707003-00002","volume":"12","author":"P Willner","year":"1997","unstructured":"Willner P . The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol 1997; 12 (Suppl 3): S7\u201314.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFmp2013115_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-010-0521-x","volume":"382","author":"Y Kitamura","year":"2010","unstructured":"Kitamura Y, Yagi T, Kitagawa K, Shinomiya K, Kawasaki H, Asanuma M et al. Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. Naunyn Schmiedebergs Arch Pharmacol 2010; 382: 151\u2013158.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFmp2013115_CR64","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuropharm.2008.06.017","volume":"55","author":"KE Bosse","year":"2008","unstructured":"Bosse KE, Jutkiewicz EM, Gnegy ME, Traynor JR . The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum. Neuropharmacology 2008; 55: 755\u2013762.","journal-title":"Neuropharmacology"},{"key":"BFmp2013115_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2008.12.021","volume":"604","author":"GP Do Carmo","year":"2009","unstructured":"Do Carmo GP, Folk JE, Rice KC, Chartoff E, Carlezon WA Jr., Negus SS . The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur J Pharmacol 2009; 604: 58\u201365.","journal-title":"Eur J Pharmacol"},{"key":"BFmp2013115_CR66","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","volume":"59","author":"EJ Nestler","year":"2006","unstructured":"Nestler EJ, Carlezon WA Jr. . The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: 1151\u20131159.","journal-title":"Biol Psychiatry"},{"key":"BFmp2013115_CR67","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature11740","volume":"493","author":"KM Tye","year":"2012","unstructured":"Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2012; 493: 537\u2013541.","journal-title":"Nature"},{"key":"BFmp2013115_CR68","doi-asserted-by":"crossref","unstructured":"Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S et al. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med 2010; 2, 54ra76.","DOI":"10.1126\/scitranslmed.3001079"},{"key":"BFmp2013115_CR69","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11713","volume":"493","author":"D Chaudhury","year":"2012","unstructured":"Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2012; 493: 532\u2013536.","journal-title":"Nature"},{"key":"BFmp2013115_CR70","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1038\/npp.2012.121","volume":"37","author":"DJ Christoffel","year":"2012","unstructured":"Christoffel DJ, Golden SA, Heshmati M, Graham A, Birnbaum S, Neve RL et al. Effects of inhibitor of kappaB kinase activity in the nucleus accumbens on emotional behavior. Neuropsychopharmacology 2012; 37: 2615\u20132623.","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2013115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013115","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:20:43Z","timestamp":1648783243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2013115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,24]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["BFmp2013115"],"URL":"https:\/\/doi.org\/10.1038\/mp.2013.115","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,24]]},"assertion":[{"value":"11 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}